Verition Fund Management LLC Bausch Health Companies Inc. Call Options Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$6.09 - $7.93 $32,277 - $42,029
-5,300 Reduced 10.13%
47,000 $295,000
Q3 2022

Nov 14, 2022
BUY
$4.58 - $9.21 $67,784 - $136,308
14,800 Added 39.47%
52,300 $360,000
Q2 2022

Aug 15, 2022
SELL
$7.06 - $23.63 $88,250 - $295,375
-12,500 Reduced 25.0%
37,500 $313,000
Q4 2021

May 03, 2022
SELL
$23.0 - $29.01 $188,600 - $237,882
-8,200 Reduced 14.09%
50,000 $1.38 Million
Q2 2021

Aug 16, 2021
BUY
$27.43 - $32.7 $1.6 Million - $1.9 Million
58,200 New
58,200 $1.71 Million

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.66B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email